Literature DB >> 16679476

Chickenpox, chickenpox vaccination, and shingles.

P D Welsby1.   

Abstract

Chickenpox in the United Kingdom, where vaccination is not undertaken, has had a stable epidemiology for decades and is a routine childhood illness. Because of vaccination, chickenpox is now a rarity in the USA. In the UK vaccination is not done because introduction of a routine childhood vaccination might drive up the age at which those who are non-immune get the illness (chickenpox tends to be more severe the older you are), and the incidence of shingles may increase. The United Kingdom is waiting to see what happens in countries where vaccination is routine.

Mesh:

Substances:

Year:  2006        PMID: 16679476      PMCID: PMC2563790          DOI: 10.1136/pgmj.2005.038984

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  21 in total

1.  The management of post-herpetic neuralgia.

Authors:  A L Cunningham; R H Dworkin
Journal:  BMJ       Date:  2000-09-30

2.  Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles.

Authors:  M C Schuette; H W Hethcote
Journal:  Bull Math Biol       Date:  1999-11       Impact factor: 1.758

3.  Varicella disease after introduction of varicella vaccine in the United States, 1995-2000.

Authors:  Jane F Seward; Barbara M Watson; Carol L Peterson; Laurene Mascola; Jan W Pelosi; John X Zhang; Teresa J Maupin; Gary S Goldman; Laura J Tabony; Kimberly G Brodovicz; Aisha O Jumaan; Melinda Wharton
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

Review 4.  Herpes zoster in older adults.

Authors:  K Schmader
Journal:  Clin Infect Dis       Date:  2001-04-17       Impact factor: 9.079

5.  Epidemiology of varicella zoster virus infection in Canada and the United Kingdom.

Authors:  M Brisson; W J Edmunds; B Law; N J Gay; R Walld; M Brownell; L L Roos; L Roos; G De Serres
Journal:  Epidemiol Infect       Date:  2001-10       Impact factor: 2.451

6.  Modelling the impact of immunization on the epidemiology of varicella zoster virus.

Authors:  M Brisson; W J Edmunds; N J Gay; B Law; G De Serres
Journal:  Epidemiol Infect       Date:  2000-12       Impact factor: 2.451

7.  Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study.

Authors:  Sara L Thomas; Jeremy G Wheeler; Andrew J Hall
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

8.  Risk of cancer after herpes zoster: a population-based study.

Authors:  M W Ragozzino; L J Melton; L T Kurland; C P Chu; H O Perry
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

Review 9.  What does epidemiology tell us about risk factors for herpes zoster?

Authors:  Sara L Thomas; Andrew J Hall
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

10.  Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox.

Authors:  M Brisson; N J Gay; W J Edmunds; N J Andrews
Journal:  Vaccine       Date:  2002-06-07       Impact factor: 3.641

View more
  4 in total

1.  Herpes zoster eye complications: rates and trends.

Authors:  Barbara P Yawn; Peter C Wollan; Jennifer L St Sauver; Linda C Butterfield
Journal:  Mayo Clin Proc       Date:  2013-05-09       Impact factor: 7.616

Review 2.  Postherpetic neuralgia: epidemiology, pathophysiology, and pain management pharmacology.

Authors:  Theresa Mallick-Searle; Brett Snodgrass; Jeannine M Brant
Journal:  J Multidiscip Healthc       Date:  2016-09-21

3.  Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategy.

Authors:  Lara Goscé; Joanne R Winter; Graham S Taylor; Joanna E A Lewis; Helen R Stagg
Journal:  Sci Rep       Date:  2019-06-26       Impact factor: 4.379

4.  Varicella and herpes zoster in Madrid, based on the Sentinel General Practitioner Network: 1997-2004.

Authors:  Napoleón Pérez-Farinós; María Ordobás; Cristina García-Fernández; Luis García-Comas; Soledad Cañellas; Inmaculada Rodero; Angeles Gutiérrez-Rodríguez; Juan García-Gutiérrez; Rosa Ramírez
Journal:  BMC Infect Dis       Date:  2007-06-15       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.